Topical 0.03% tacrolimus for treatment of pemphigus erythematosus in a Korea Jindo dog.
Topical 0.03% tacrolimus was used for treatment of a Korea Jindo dog diagnosed with pemphigus erythematosus. The dog was slowly improved following application of tacrolimus but did not achieve complete remission until end of this study. No adverse effects on clinical or laboratory parameters were noted during the topical tacrolimus therapy period.
Bhang
Dong-Ha
DH
Department of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University, Seoul, South Korea.
Choi
Ul-Soo
US
Jung
Yun-Chan
YC
Kim
Min-Kyu
MK
Choi
Eun-Wha
EW
Seo
Kyoung-Won
KW
Kang
Min-Soo
MS
Hwang
Cheol-Yong
CY
Kim
Dae-Yong
DY
Youn
Hwa-Young
HY
Lee
Chang-Woo
CW
D000287:Administration, Topical; D000818:Animals; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D005260:Female; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D010392:Pemphigus / Q000188:drug therapy / Q000473:pathology / Q000662:veterinary*; D012867:Skin / Q000473:pathology; D016559:Tacrolimus / Q000008:administration & dosage / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D016559:Tacrolimus